What is the Impact Factor of Mabs?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Mabs is 7.90, ranking in quartile Q1 of Web of Science (SCIE).

Is Mabs indexed in Web of Science or Scopus?

Yes, Mabs is indexed in Web of Science (SCIE, Q1 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 2.065 (Q1) and an H-index of 117.

Who publishes Mabs and what is the Article Processing Charge (APC)?

Mabs is published by Landes Bioscience. The estimated Article Processing Charge (APC) is approximately $3,766 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Mabs?

The official ISO-4 abbreviation of Mabs is "MABS-AUSTIN". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q1Scopus Q1SCImago #1,353Gold OA

Mabs

Abbreviation (ISO):MABS-AUSTIN

•

Identifier (ISSN):1942-0862(Print)/1942-0870(Online)

•

Publisher:Landes Bioscience

Official Website Submission Portal Compare

Clarivate IF (2026)

7.9↑ +0.6

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIEJCR Quartile

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Mabs

WoS Q1

Annual Impact Factor Metric

Current (2026):7.9

Scopus SJR & RankScopus Q1

2.065

#1,353

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

117

117 papers with at least that number of citations each

WoS: SCIE / JCRQ1

Self-Citation Rate12.5%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessGold OA

100articles/year

100% Gold OA•87.21% Original Research

Aims & Scope

mAbs is a multi-disciplinary journal dedicated to the art and science of antibody research and development. The journal has a strong scientific and medical focus, but also strives to serve a broader readership. The articles are thus of interest to scientists, clinical researchers, and physicians, as well as the wider mAb community, including our readers involved in technology transfer, legal issues, investment, strategic planning and the regulation of therapeutics.

Topics Covered (Recognized by AI)

Biology94%Genetics90%Medicine89.5%Immunology83.7%Chemistry83.2%Antibody80.3%Biochemistry68%Monoclonal antibody55.1%Internal medicine50.9%Antigen35.2%Physics34.5%Gene30.4%Immune system28.5%Computational biology27.5%Molecular biology26.3%Computer science25.6%Receptor24.1%Organic chemistry23.7%Nuclear magnetic resonance21%

Primary Research Areas

Engineering & Technology Instruments & Instrumentation

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

MEDICINE, RESEARCH & EXPERIMENTAL

Rank25/191

IndexSCIE

JCISCIE2026

MEDICINE, RESEARCH & EXPERIMENTAL

Rank19/191

IndexSCIE

Category	Index	Rank	Quartile
MEDICINE, RESEARCH & EXPERIMENTAL	JCRSCIE	25/191	Q1
MEDICINE, RESEARCH & EXPERIMENTAL	JCISCIE	19/191	Q1

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF7.9

Articles / Year87

Total Citations106

2025

IF7.3

Articles / Year132

Total Citations898

2024

IF5.6

Articles / Year99

Total Citations1,590

2023

IF5.3

Articles / Year95

Total Citations2,820

2022

IF6.44

Articles / Year89

Total Citations2,883

Year	Impact Factor	Articles / Year	Total Citations
2026	7.9	87	106
2025	7.3	132	898
2024	5.6	99	1,590
2023	5.3	95	2,820
2022	6.44	89	2,883
2021	5.857	105	3,620
2020	4.634	98	2,918
2019	4.405	111	4,631
2018	5.165	114	5,959
2017	—	115	5,844
2016	—	143	7,108
2015	—	125	8,123

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #1,353Scopus Q1SCImago Profile

Scopus Coverage:2009-2026

•

Scopus Broad Areas:Immunology and MicrobiologyMedicine

Scopus Citation Rank (SJR)Q1

2.065

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1

Citations / Doc (2 years)

7.59

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$3,766 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations2,082

3-Year Documents280

Citable Documents277

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate39.2%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

ImmunologyQ1

Immunology and AllergyQ1

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 12.5%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

2区 (Zone 2)Medicine

Minor Category (Specific Field):

2区MEDICINE, RESEARCH & EXPERIMENTAL

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Mabs (abbr: MABS-AUSTIN, ISSN: 1942-0862) is a peer-reviewed international scholarly journal in the field of Engineering & Technology, published by Landes Bioscience in United States since 2009. The periodical holds a Journal Impact Factor (JIF) of 7.90, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 2.065 (Q1), an H-index of 117.

The journal enforces rigorous peer evaluation with a publication frequency of Bimonthly, an annual output of approximately 100 scientific articles. In terms of accessibility and author fees, it operates under the Gold OA model with an estimated APC of $3,766 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.